Cannabinoids for the treatment of agitation and aggression in alzheimer’s disease. Tim Karl, another study originating out of Australia involved genetically engineered mice that had been treated with daily injections with 20 mg/kg of CBD for three weeks. 2015;29(8):615–23. CNS Drugs. Read More
The post Cannabinoids for the treatment of agitation and aggression in alzheimer’s disease appeared first on Dagga Magazine.